Are LRRK2 p.G2019S or GBA1 variants associated with long-term outcomes of deep brain stimulation for Parkinson's disease?
Authors:
- 21 January 2024
- journal article
- research article
- Published by Elsevier in Parkinsonism & Related Disorders
- Vol. 124, 106008
Abstract
No abstract availableKeywords
Funding Information
- Sheba Hospital
This publication has 11 references indexed in Scilit:
- Should we offer deep brain stimulation to Parkinson’s disease patients with GBA mutations?Frontiers in Neurology, 2023
- Parkinson Disease and Subthalamic Nucleus Deep Brain Stimulation: Cognitive Effects in GBA Mutation CarriersAnnals of Neurology, 2022
- Early cognitive decline after bilateral subthalamic deep brain stimulation in Parkinson's disease patients with GBA mutationsParkinsonism & Related Disorders, 2020
- Genetic background and outcome of Deep Brain Stimulation in Parkinson's diseaseParkinsonism & Related Disorders, 2019
- Deep Brain Stimulation in Patients With Mutations in Parkinson's Disease–Related Genes: A Systematic ReviewMovement Disorders Clinical Practice, 2019
- Association of Subthalamic Deep Brain Stimulation With Motor, Functional, and Pharmacologic Outcomes in Patients With Monogenic Parkinson DiseaseJAMA Network Open, 2019
- GBA-Associated Parkinson’s Disease and Other SynucleinopathiesCurrent Neurology and Neuroscience Reports, 2018
- Simplified conversion method for unified Parkinson's disease rating scale motor examinationsMovement Disorders, 2015
- GBA‐associated Parkinson's disease: Reduced survival and more rapid progression in a prospective longitudinal studyMovement Disorders, 2014
- The LRRK2 G2019S mutation status does not affect the outcome of subthalamic stimulation in patients with Parkinson's diseaseParkinsonism & Related Disorders, 2013